Goldman Sachs, JP Morgan, Morgan Stanley to reap big benefits from Pfizer merger
BOUTIQUE BONANZA: 3 small Wall Street firms grabbed big roles on the Pfizer-Allergan megadeal
"Pfizer has agreed on a deal to combine with Allergan in a $160 billion transaction that will be among the biggest deals of all time.
And three small Wall Street firms are in on the action.
Guggenheim Partners, Centerview Partners and Moelis & Company are all advising Pfizer on the transaction alongside Goldman Sachs.
The four banks will split more than $100 million in deal fees, according to Jeffrey Nassof of the mergers and acquisitions consulting firm Freeman & Co.
JPMorgan and Morgan Stanley are advising Allergan on the transaction."
http://www.businessinsider.com/pfizer-allergan-deal-boutque-advisers-2015-11
******
so the big banks and the big pharms are getting a bonanza. Sanders has come out against this merger, and based on his opposition to previous mergers, OM can be expected to be against it. We need Clinton to come out and join them. these inversion scams are ripping off the citizens and making the big companies rich. hillary needs to cut her wall street ties and wage war on this duplicitous theft of the taxpayer. but will she?
= new reply since forum marked as read
